Purchase Order 36C25926P0334
- Not listed
- Vericel Corporation, a Cambridge, Massachusetts-based medical technology company specializing in advanced cell therapy and tissue engineering, has been awarded a firm fixed-price purchase order valued at $69,772 by the Department of Veterans Affairs through Veterans Integrated Service Network 6. The award, issued on January 20, 2026, with an ultimate completion date of January 27, 2026, represents a direct procurement with no set-aside designation. Based on Vericel's established contract history...
- This federal contract award is for the supply of a surgical implant (tissue) by Vericel Corporation, a for-profit manufacturer of advanced cell therapy products, to the Department of Veterans Affairs (VA). The $52,252.00 firm fixed price purchase order is not set aside and has a completion date of June 26, 2023. Vericel, which has been a registered federal contractor since 2015, has secured over 50 contracts with the VA's Veterans Health Administration, primarily to provide specialized medical...
- This federal contract award, valued at $56,171.00, was issued by the Veterans Integrated Service Network 12 (VISN 12), which is part of the U.S. Department of Veterans Affairs (VA). The contract was awarded to Vericel Corporation, a for-profit manufacturer of advanced cell therapy products, primarily for the supply of the company's MACI cultured chondrocyte implant and other surgical implants, membranes, and biological products. The contract is a firm fixed price purchase order with a completion...
- This federal contract award, with an ID of 36C25225P0240, was issued by the Department of Veterans Affairs (VA) to Vericel Corporation, a for-profit medical technology company based in Cambridge, Massachusetts. The $56,171.00 firm fixed-price purchase order is for the delivery of IMPLANT products, which are likely advanced cell therapy and surgical implants used in orthopedic and reconstructive procedures. The contract has no set-aside designation, indicating it was competed on the open...
- This is a firm fixed price purchase order contract awarded by the Department of Veterans Affairs (VA) to Vericel Corporation, a for-profit manufacturer of advanced cell therapy products. The $52,252 contract is for the delivery of surgical implants, with a period of performance ending on November 22, 2023. Vericel Corporation is a registered federal contractor that has secured over 50 contracts with the VA and the Defense Health Agency since 2015, primarily to provide specialized medical...
- This federal contract award to Vericel Corporation, a for-profit manufacturer of advanced cell therapy products, is for the supply of PROS - SURGICAL IMPLANT valued at $56,171.00. The contract is a firm fixed price purchase order awarded by the Veterans Integrated Service Network 19, a component of the U.S. Department of Veterans Affairs (VA), to support healthcare services for veterans and military personnel. The contract is not set aside for any specific business designation. Vericel...
- This federal contract award, valued at $56,171.00, was made by the U.S. Department of Veterans Affairs (VA) to Vericel Corporation, a for-profit manufacturer of advanced cell therapy products. The contract is for the provision of IMPLANT, a surgical implant product, with an ultimate completion date of August 16, 2024. This contract was not set aside for a specific business type. Vericel Corporation, a long-standing federal contractor since 2015, has secured numerous contracts with the VA and the...
- This is a firm fixed price purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Vericel Corporation, a for-profit manufacturer of advanced cell therapy products for sports medicine and severe burn care. The $56,171 contract is for the delivery of surgical implants, membranes, and other biological products to support healthcare services for veterans at VA facilities. The contract has a completion date of May 29, 2024 and was awarded on March...
- This $56,171 firm fixed price purchase order was awarded by the U.S. Department of Veterans Affairs' Veterans Integrated Service Network 21 to Vericel Corporation, a for-profit manufacturer of advanced cell therapy products. The contract is for the supply of MACI (matrix-induced autologous chondrocyte implantation) cultured chondrocyte implants, surgical implants, membranes, and other related products to support orthopedic and reconstructive healthcare services for veterans. Vericel...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 awarded a $52,252 firm fixed price purchase order to Vericel Corporation, a for-profit manufacturer of goods located in Cambridge, MA. The order is for surgical implants to support VHA programs, with delivery required by January 31, 2024. No subcontractors or set-aside designations were specified. As the sole awardee, Vericel Corporation will provide the surgical implants to aid Veterans...
Vericel Corporation, a Cambridge, Massachusetts-based medical technology company specializing in cell therapy and tissue engineering, was awarded a firm fixed-price purchase order valued at $69,772 by the Department of Veterans Affairs' Veterans Integrated Service Network 19 on March 13, 2026. The contract, which carries no set-aside designation and reflects open market competition, has an ultimate completion date of May 13, 2026. As the prime contractor, Vericel will deliver prosthetic implants to support orthopedic and reconstructive healthcare services for veterans, with performance taking place at the company's Cambridge headquarters. This award aligns with Vericel's established role as a primary supplier of advanced surgical implants to the VA, including specialized products such as matrix-induced autologous chondrocyte implantation cultured chondrocyte implants and cartilage grafts used in orthopedic procedures. The contract value falls within the typical range of Vericel's federal purchase orders with the VA, which generally range from approximately $43,000 to $111,000. The firm's consistent contract activity with Veterans Integrated Service Networks across multiple regions underscores its recognized capability in delivering specialized biological and surgical products for veteran healthcare.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $69.8k | 3/12/26 |